Neopterin as a marker for immune system activation in coal workers' pneumoconiosis

Toxicology and Industrial Health

Volumn 23, Issue 3, 2007, Pages 155-160

  Ulker, Ozge C ^a   Yucesoy, Berran ^a   Durucu, Murat ^b   Karakaya, Asuman ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Zonguldak Chest and Occupational Disease Hospital   (Turkey)

Author keywords

biomarker; cell mediated immunity; coal workers' pneumoconiosis; neopterin

Indexed keywords

CREATININE; NEOPTERIN;

ADULT; AGED; ARTICLE; COAL WORKER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; IMMUNE SYSTEM; INDUSTRIAL WORKER; LUNG LAVAGE; MAJOR CLINICAL STUDY; PNEUMOCONIOSIS; SMOKING HABIT; URINALYSIS;

AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COAL MINING; HUMANS; IMMUNITY, CELLULAR; MIDDLE AGED; NEOPTERIN; PNEUMOCONIOSIS;

EID: 36549024508     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233707083527     Document Type: Article

References (26)

1. Altindag, Z.Z., Baydar, T., Isimer, A. et al. 2003: Neopterin as a new biomarker fort he evaluation of occupational exposure to silica. International. Archive of Occupational and Environmental Health 76, 318—22.
2. Berdowska, A. and Zwirska-Korczala, K. 2001: Neopterin measurement in clinical diagnosis. Journal of Clinical Pharmacy and Therapeutics 267, 319—29.
3. Blasko, I., Knaus, G., Weiss, E. et al. 2007: Cognitive deterioration in Alzheimers’ disease is accompanied by increase of plasma neopterin. Journal of Psychiatric Research 41, 694—701.
4. Borm, P.J.A. and Shins, R.P.F. 2001: Genotype and phenotype in susceptibility to coal workers’ pneumoconiosis. The use of cytokines in perspective. European Respiratory Journal 18, Supplement 132, 127a—33.
5. Castranova, V. and Vallyathan, V. 2000: Silicosis and coal workers’ pneumoconiosis. Environmental Health Perspectives 108, 675—84.
6. Enelow, R.I., Mohammed, A.Z., Stoler, M.H. et al. 1998: Structural and functional consequences of alveolar cell recognition by CD8+ T lymphocytes in experimental lung disease. Journal of Clinical Investigation 102, 1653—61.
7. Hamerlinck, F.F. 1999: Neopterin: a review. Experimental Dermatology 8, 167—76.
8. Hoffmann, G., Wirleitner, B. and Fuchs, D. 2003: Potential role of immune system activation—associated production of nepopterin derivates in humans. Inflammation Research 52, 313—21.
9. Johnston, D.T., Gagos, M., Raio, N. et al. 2006: Alterations in serum neopterin correlate with thromboslysis in myocardial infarction risk scores in acute coronary syndromes. Coronary Artery Disease 17, 511—16.
10. MacNee, W., Rahman, I. 2001: Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends in Molecular Medicine 7, 55—62.
11. Maier, L.A., Kitle, L.A., Mroz, M.M. et al. 2003: Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. American Journal of Industrial Medicine 43, 592—601.
12. Melichar, B., Solichova, D. and Freedman, R.S. 2006: Neopterin as an indicator of immune activation and pronosis in patients with gynecological malignancies. International Journal of Gynecological Cancer 16, 240—52.
13. Millner, M.M., Franthal, W. and Thalhamer, G.H. 1998: Neopterin concentrations in cerebrospinal fluid and serum as an aid differentiating central nervous system and peripheral infections in children. Clinical Chemistry 44, 161—67.
14. Mohamed, K.H., Mobasher, A.A.M.T., Yousef, A.R.I. et al. 2001: BAL Neopterin: a novel marker for cell-mediated immunity in patişents with pulmonary tuberculosis and lung cancer. Chest 119, 776—80.
15. Murr C., Fuith L.C., Widner B. et al. 1999: Increased neopterin concentrations in patients with cancer: ındicator of oxidative stress? Anticancer Research 19, 1721—28.
16. Murr C., Widner B., Wirleitner B. et al. 2002: Neopterin as a marker for immune system activation. Current Drug Metabolism 3, 175—87.
17. Müller M.M., Curtius H.Ch., Herold M. et al. 1991: Neopterin in clinical practice. Clinica Chimica Acta 201, 1—16.
18. Pinho, R.A., Bonatto, F., Andrades, M. et al. 2004: Lung oxidative response after acute coal dust exposure. Environmental Research 96, 290—97.
19. Prakova, G., Gidikova, P., Slavov, E. et al. 2005: The potential role of neopterin as a biomarker for silicosis. Trakia Journal of Sciences 3, 37—41.
20. Razzaque, M.S. and Taguchi, T. 2003: Pulmonary fibrosis: cellular and molecular events. Pathology International 53, 133—45.
21. Turkey Hard Coal Enterprise. 2004, http://www.taskomuru.gov.tr.
22. Vallyathan, V., Shi, X. and Castranova, V. 1998: Reactive oxygen species: their relation to pneumoconiosis and carcinogenesis. Environmental Health Perspectives 106, 1151—55.
23. Vanhee, D., Gosset, P., Wallaert, B. et al. 1994: Mechanisms of fibrosis in coal workers’ pneumoconiosis. American Journal of Respiratory Critical Care Medicine 150, 1049—55.
24. Vanhee, D., Gosset, P., Boitelle, A. et al. 1995: Cytokines and cytokine network in silicosis and coal workers’ pneumoconiosis. European Respiratory Journal 8, 834—42.
25. Ward, P.A. and Hunninghake, G.W., 1998: Lung inflammation and fibrosis. American Journal of Respiratory Critical Care Medicine 157, 123—29.
26. Wirleitner, B., Schroecksnadel, K., Winkler, C. et al. 2005: Neopterin in HIV-1 infection. Molecular Immunology 42, 183—94.